Projects funded by the NCN
Molecular Pathogenesis and Precision Antisense Oligonucleotide Therapy for BAG3-Related Myofibrillar Myopathy Type 6 Using Mouse and Cellular Models
2025/57/B/NZ2/01084
Keywords:
Rare disorder Myofibrillar Myopathy Type 6 BAG3 Antisense Oligonucleotides (ASO) Molecular Mechanism Precision Medicine RNA Therapeutics Protein Aggregation Mouse Models Cardiomyocytes Neuromuscular Disorders
Descriptors:
- NZ2_14:
- NZ2_04:
- NZ2_15:
Panel:
NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 29 - announced on 2025-03-17
Amount awarded: 3 099 900 PLN
Project start date (Y-m-d): 2026-02-02
Project end date (Y-m-d): 2030-02-01
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.